P1.08D.03 Induction Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-Small Cell Lung Cancer (NSCLC)
| Autor: | Sanborn, R.E., Hanes, D., Shaker, D., Fidler, M.J., Gurubhagavatula, S., Chang, S.-C., Redmond, W.L. |
|---|---|
| Zdroj: | Journal of Thoracic Oncology; October 2024, Vol. 19 Issue: 10, Number 10 Supplement 1 pS184-S184, 1p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|